Finn Patrick John 4
4 · Twist Bioscience Corp · Filed May 6, 2026
Research Summary
AI-generated summary of this filing
Twist Bioscience (TWST) President Finn Patrick John Sells 2,844 Shares
What Happened
- Finn Patrick John, President and COO of Twist Bioscience, disposed of 2,844 shares on 2026-05-04 at $57.15 per share, generating proceeds of $162,531. The transaction is reported as a sale (S) and was done to satisfy tax withholding obligations tied to RSU vesting — a sell-to-cover rather than a discretionary open-market trade.
Key Details
- Transaction date and price: 2026-05-04 at $57.15 per share
- Total proceeds: $162,531 (2,844 shares × $57.15)
- Reason/footnote: Sell-to-cover to satisfy tax withholding on vested Restricted Stock Units (per filing footnote F1); not a discretionary sale by the insider
- Filing date: 2026-05-06 (filed two days after the transaction), which appears timely under Form 4 rules
- Shares owned after the transaction: Not provided in the summary data supplied
Context
- Sell-to-cover transactions are common when restricted stock units vest; the company or insider arranges a sale of just enough shares to pay required taxes. These transactions typically do not signal the insider’s view of the company’s prospects in the same way an intentional open-market sale might.
Insider Transaction Report
Form 4
Finn Patrick John
President and COO
Transactions
- Sale
Common Stock
[F1]2026-05-04$57.15/sh−2,844$162,531→ 278,964 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Patrick John Finn|2026-05-06